SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Liou, H-H.
Right arrow Articles by Tsai, M-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liou, H-H.
Right arrow Articles by Tsai, M-C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Review : Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients

H-H. Liou

Department of Neurology, National Taiwan University Hospital, Department of Pharmacology, College of Medicine; National Taiwan University, Taipei, Taiwan

C-R. Wang

Department of Internal Medicine, National Taiwan University Hospital

C-J. Chen

Institute of Epidemiology, College of Public Health

R-C. Chen

Department of Neurology, National Taiwan University Hospital

C-Y. Chuang

Department of Internal Medicine, National Taiwan University Hospital

I-P. Chiang

Department of Pathology, National Taiwan University Hospital

M-C. Tsai

Department of Pharmacology, College of Medicine; National Taiwan University, Taipei, Taiwan

To examine the association between anticardiolipin (aCL) antibodies and epilepsy, we inves tigated the serum titers of aCL antibodies in a total 252 systemic lupus erythematosus (SLE) patients recruited in a prospective study. Twenty-one cases with epilepsy which were not attributable to any causes other than SLE were identified after being followed-up for five years. The clinical manifestations were recorded and blood samples were tested for the presence of aCL antibodies (IgG, IgM and IgA isotypes). Among 21 patients with epilepsy, 12 (57.1%), 2 (9.5%) and 2 (9.5%), respectively, had elevated baseline serum levels of IgG, IgM and IgA aCL antibodies. There was a dose-response relationship between risk of seizure and the baseline serum level of aCL antibodies (P < 0.01). The odds ratio of developing seizure were 3.7 for those who had a high level of aCL antibodies compared with those without a detectable level of aCL antibodies as the referent. Our results indicate that epilepsy as a primary neuropsychiatric event among lupus patients is associated with a high titer of aCL antibodies.

Key Words: systemic lupus erythematosus • epilepsy • anticardiolipin antibodies

Lupus, Vol. 5, No. 4, 307-312 (1996)
DOI: 10.1177/096120339600500412


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
LupusHome page
P. Bartolucci, S. Brechignac, P. Cohen, V. Le Guern, and L. Guillevin
Adjunctive plasma exchanges to treat neuropsychiatric lupus: a retrospective study on 10 patients
Lupus, October 1, 2007; 16(10): 817 - 822.
[Abstract] [PDF]


Home page
LupusHome page
R Cimaz, P L Meroni, and Y Shoenfeld
Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome)
Lupus, April 1, 2006; 15(4): 191 - 197.
[Abstract] [PDF]


Home page
NeurologyHome page
J. Mikdashi, A. Krumholz, and B. Handwerger
Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus
Neurology, June 28, 2005; 64(12): 2102 - 2107.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
G. Sanna, M. L. Bertolaccini, M. J. Cuadrado, M. A. Khamashta, and G. R. V. Hughes
Central nervous system involvement in the antiphospholipid (Hughes) syndrome
Rheumatology, February 1, 2003; 42(2): 200 - 213.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
F. G. I. Jennekens and L. Kater
The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation
Rheumatology, June 1, 2002; 41(6): 619 - 630.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J PALACE and B LANG
Epilepsy: an autoimmune disease?
J. Neurol. Neurosurg. Psychiatry, December 1, 2000; 69(6): 711 - 714.
[Full Text] [PDF]


Home page
Arch NeurolHome page
J. A. Aarli
Epilepsy and the Immune System
Arch Neurol, December 1, 2000; 57(12): 1689 - 1692.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
F. Formiga, F. Mitjavila, M. Pac, and I. Moga
Epilepsy and antiphospholipid antibodies in systemic lupus erythematosus patients
Lupus, January 1, 1997; 6(5): 486 - 486.
[PDF]



Advertisement